LIVIA Group Acquires Biotechnology Business from Patheon in Capua, Italy

MUNICH, July 24, 2015 /PRNewswire/ --

The Munich based LIVIA Group has entered into an agreement with Patheon to acquire its 100% affiliate Patheon Capua S.p.A. based near Naples, Italy. The business is one of the world's largest independent microbial fermentation-based manufacturing facilities with 1,400m³ production capacity. Capua supplies its international customers in more than 60 countries with enzymes, therapeutic proteins and high-value small molecules for applications in the food, feed, pharma, agrochemical and fine chemical industry. The production facility is both FDA and EMEA (Pharma cGMPs) approved as well as ISO 14001 certified.

For LIVIA Group this acquisition already represents the fifth transaction in 2015. At the beginning of the year, LIVIA jointly invested with Remondis in the Indian market by acquiring a 50% share in Orgatreatments Pvt. Ltd. located in the Maharaschda province. The aim is to develop the company to become the leading bio waste recycling business.

Shortly after, LIVIA took over SNT Deutschland AG, one of the largest call center operations in Germany, from the Dutch telecommunication company KPN.

In February, following the successful repositioning in the market, LIVIA divested its affiliate DTP AG to a group of investors. DTP is a highly specialized producer of precision tubes made of zirconium and titanium alloys for the nuclear, aerospace and chemical as well as oil and gas industry.

In the agricultural sector, LIVIA was able to acquire in March the international oriented winery Vergenoegd in the renowned Stellenbosch area. The foundation of the business dates back to 1696 and on ca. 120ha of land the winery produces approximately 500,000 liters of wine per annum.

At last, LIVIA Group acquired the majority of the share capital of Softmatic AG, which is traded on the regulated market of the Frankfurt stock exchange.

LIVIA Group employs ca. 4,700 people and generates consolidated sales of ca. EUR 500m.

About LIVIA Group 

With funds under management amounting to more than EUR 500m, LIVIA Group is an independent industrial holding company and the investment firm of Prof Dr Dr Peter Löw, concentrating on a diverse spectrum of assets ranging from corporate, real estate, agricultural, emerging markets and opportunistic investments. LIVIA Corporate Investments is specializing in acquiring European corporate spin-offs / carve-outs and midsized companies with i) development potential through operational engagement, ii) below industry average profitability, iii) restructuring or transformation needs, or iv) synergies with existing portfolio-investments and a revenue size between EUR 20m and EUR 1.5bn. With over 220 successfully executed transactions, LIVIA's management has become a trusted partner among international corporates.

About Patheon 

Patheon is a leading global provider of outsourced pharmaceutical development and manufacturing services. With approximately 8,700 employees worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle.

Contact:
LIVIA Group
Alter Hof 5
Tel. +49-89-5527-58-0